Biotech News
News | Bavarian Nordic
July 06, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
June 29, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
June 29, 2026 | Press Releases
Bavarian Nordic Receives Health Canada Approval for Chikungunya Vaccine
June 22, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
June 15, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
June 09, 2026 | Company Announcements
Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine
June 08, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
June 02, 2026 | Company Announcements
Bavarian Nordic Launches Next Tranche of Share Buy-Back Program
May 13, 2026 | Company Announcements
Bavarian Nordic Announces Interim Results for the First Three Months of 2026
May 11, 2026 | Company Announcements
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox Vaccines
May 11, 2026 | Company Announcements
Bavarian Nordic – Completion of Share Buy-Back Program
May 04, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
April 27, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
April 21, 2026 | Company Announcements
Resolutions of the Annual General Meeting 2026 of Bavarian Nordic A/S
April 20, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
April 16, 2026 | Press Releases
Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine
April 13, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
April 07, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
March 30, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
March 27, 2026 | Press Releases
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years
March 24, 2026 | Company Announcements
Bavarian Nordic A/S – Notice Convening Annual General Meeting
March 23, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
March 16, 2026 | Company Announcements
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
March 12, 2026 | Company Announcements
Bavarian Nordic Launches Next Tranche of Share Buy-Back Program
March 12, 2026 | Company Announcements
Bavarian Nordic Publishes Annual Report 2025